Zenith Drugs Limited, together with its subsidiaries, manufactures and trades in branded, generic, and OTC medicines. The company offers a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets. Its products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. The company operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. Zenith Drugs Limited was incorporated in 1956 and is based in Indore, India.
| Current Price | ₹49.10 |
|---|---|
| Market Cap | ₹90 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Non-Prescription Drugs; Pharmaceutical Products; Anti-infective Drugs; Generic Pharmaceuticals |
| P/E Ratio | 21.3 |
| 52-Week Range | ₹33.30 – ₹77.00 |
| Beta (1Y) | 0.95 |
| Dividend Yield | 0.00% |
1. Manufacturing and Trading of Medicines-100%
Zenith Drugs Limited is trading at ₹49.10, with a market capitalisation of ₹90 Cr.
Zenith Drugs Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Non-Prescription Drugs; Pharmaceutical Products; Anti-infective Drugs; Generic Pharmaceuticals).
Zenith Drugs Limited has a P/E of 21.3.